Bensheim - The Christoffel-Blindenmission (CBM) has been able to increase its donation income unusually strongly in the past year. They have risen from 51.2 million euros to 235 million euros, which means an increase of 183.8 million euros, as the aid organization announced today at the presentation of its 2017 annual report in Bensheim.
"The largest share A drug donation program by Merck Sharp and Dohme () to combat river blindness, for which we have assumed overall responsibility from 2017, was responsible for this, ”said the reason. This program against the tropical disease, which damages the eyes, is reported as donation in kind of 179.5 million euros.
At the same time, donations from private donors also increased in 2017, by more than six percent from 46.5 to 49.5 million euros. Further income came from estates and public funds.
A programmatic focus in 2017 was the improvement of ophthalmic care for children in developing countries. "Numerous children and adults go blind, although it could be avoided," said CBM board member Rainer Brockhaus. There is lack of clinics and well-trained staff. In 2017, the CBM was able to increase the number of cataract operations in children from just under 12,000 to almost 41,000. More than half of these children had been operated on as part of new project in Kenya.
The Christoffel Blindenmission has supported people with disabilities in developing countries for 110 years. According to its own information, the aid organization currently supports 530 projects in 54 countries.